收藏切换
The cultivation practice of drug regulatory science talents in the United States under the background of regulatory science and its enlightenment to China
收藏切换
Liang HE1, Chen-dong DONG2, Ning-ying MAO1, Jun LI1
Chinese Journal of New Drugs | 2021, 30(5) : 385 - 393
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(5): 385-393
The cultivation practice of drug regulatory science talents in the United States under the background of regulatory science and its enlightenment to China
Full
Liang HE1, Chen-dong DONG2, Ning-ying MAO1, Jun LI1
Affiliations
  • 1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China
  • 2China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Shenzhen 518110, China
Published: 2021-03-15
Outline
收藏切换

The research and construction of drug regulatory science has become the focus of drug supervision strategies in the world in this century, and the construction of talent teams is one of the first considerations in the research and construction of regulatory science. China is still in its infancy in the cultivation of regulatory science talents, and there are prominent problems such as the small scale, shallow degree, and chaotic system of talent cultivation. The United States has been exploring the cultivation of talents for drug regulatory science for many years, and has formed a mature regulatory science talent training system. This article studies the innovative practice of the training of regulatory science talents in the United States, analyzes and summarizes its talent training orientation and specific training measures to understand the deficiencies in China, and on the basis of which, suggestions were put forward to improve the cultivation system of drug regulatory science talents in China.

regulatory science  /  talent training  /  competency
贺亮, 董晨东, 茅宁莹, 李军. 美国药品监管科学人才培养实践探究及对我国的启示. 中国新药杂志, 2021 , 30 (5) : 385 -393 .
Liang HE, Chen-dong DONG, Ning-ying MAO, Jun LI. The cultivation practice of drug regulatory science talents in the United States under the background of regulatory science and its enlightenment to China[J]. Chinese Journal of New Drugs, 2021 , 30 (5) : 385 -393 .
Year 2021 volume 30 Issue 5
27
11
Cite this Article
BibTeX
Article Info
  • Online Date:2026-10-29
  • Published:2021-03-15
Article Data
Affiliations
History
  • Accepted:2020-06-10
Funding
Affiliations
    1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, China
    2China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Shenzhen 518110, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT